Skip to content

NJ ME/CFSA

This website is secure – as evidenced by “https” preceeding the web address. 3/05/2019

  • Home
  • About ME/CFS
  • Links
  • Contact Us
  • Support Groups
  • Scholarships
  • Anesthesia
  • Disability
  • Resources
  • Primers
  • Toggle search form

Category: Breaking News

#GivingTuesday

Posted on November 27, 2016November 27, 2016 By Pat

This is the season of giving. Tuesday is National Day of Giving!

Be a part of #GivingTuesday – DONATE to NJME/CFSA!

NJ/MECFSA is a 501(c)(3) non-profit organization.

DONATE at http://www.njcfsa.org/donate/

If you prefer there is also https://www.gofundme.com/ArpitaSheth-MyME (funds also go directly to the organization

Breaking News

Scholarships

Posted on October 17, 2016October 17, 2016 By Pat

The 2016 Scholarships have been posted.  Click on the “Scholarships” tab above.  The Medical Scholarship winner and runner-up essays are at that site.

Breaking News

Info from Bateman Horne Center

Posted on October 11, 2016October 11, 2016 By Pat

https://batemanhornecenter.org/assess-orthostatic-intolerance/

Breaking News, Resources

Gene Study

Posted on October 9, 2016October 9, 2016 By Pat

Dr. Nancy Klimas’ ME/CFS Gene Study at Nova Southeast University is still seeking patient and healthy volunteers. If you are interested, you can send a message to Helpdesk@njmecfsa.org and we will forward it to the study. More information can be found at https://sharkmedia.nova.edu/m…/ME+CFS+Genes+Study/1_06vh90p0

This is a chance for both patients and healthy volunteers to participate.

Breaking News

Follow-Up to Letter to NIH Director Collins

Posted on September 10, 2016September 10, 2016 By Pat

Read about the encouraging results at:

Members of Congress Urge NIH Director Francis Collins to Strengthen Biomedical Research into Myalgic Encephalomyelitis / Chronic Fatigue Syndrome

Breaking News

First Approved ME/CFS Treatment in the World

Posted on August 23, 2016 By Pat

Hemispherx Biopharma Announces Major Breakthrough:
Approval for Commercial Sale of Rintatolimod (U.S. Tradename: Ampligen®) to Treat Severe Cases of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in the Argentine Republic First Product Approved for ME/CFS Indication Anywhere in the World.

Ampligen Approved in Argentina – First in the World 2016-08-23

Breaking News

Posts pagination

Previous 1 … 9 10 11 … 22 Next

CRISIS INFO
SEEK HELP
CALL 988

DONATE or PAY DUES
Click Here
Subscribe to NJ ME/CFSA by email!
Please enable JavaScript in your browser to complete this form.
Name *
Loading

About NJMECFSA

We are patients and families with ME/CFS. We are here to support, inform and help you to deal with this serious illness.

Secure Website

This website is secure – as evidenced by “https” preceeding the web address. -3/05/2019

ICD-10!!!

Share this code information with your health care providers in order to have ME/CFS recognized and acknowledged properly

Copyright © 2025 NJ ME/CFSA.

Powered by PressBook Premium theme